(Q84963994)
Statements
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma (English)
J Stebbing
A Dalgleish
A Gifford-Moore
A Martin
C Gleeson
G Wilson
L R Brunet
J Grange
19 September 2011